ArticleScientific reports2026
Study on the relationship between coagulation function, homocysteine, serum oxidative stress and sudden deafness and its clinical implications.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hyperhomocysteinemia in sudden sensorineural hearing loss: Evidence from a prospective clinical study.PloS one · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sudden sensorineural hearing loss (SSHL) is characterized by an abrupt, unexplained decline in hearing, typically affecting one ear. Although coagulation abnormalities, homocysteine (Hcy), and oxidative stress have been implicated in SSHL, their combined diagnostic value remains insufficiently defined. This study aimed to investigate the associations between coagulation parameters, Hcy, oxidative stress markers, and SSHL, and to evaluate their diagnostic significance. Ninety-five patients with SSHL and 95 age- and sex-matched healthy controls were enrolled between February 2022 and February 2023. Coagulation indices (APTT, INR, TT, fibrinogen [FIB], and D-dimer), Hcy, and oxidative stress markers (nitric oxide [NO], endothelin [ET], and plasma superoxide dismutase [P-SOD]) were measured. Compared with controls, SSHL patients had significantly lower FIB and higher D-dimer levels (both P < 0.05). NO and P-SOD were decreased, whereas ET was elevated (P < 0.05). Multivariate logistic regression identified lower FIB (OR = 0.356, 95% CI: 0.204–0.620, P < 0.001) and lower P-SOD (OR = 0.152, 95% CI: 0.043–0.542, P = 0.004) as independent factors associated with SSHL, while elevated Hcy significantly increased disease risk (OR = 6.417, 95% CI: 1.22–33.89, P = 0.029). Receiver operating characteristic analysis demonstrated good diagnostic performance for individual biomarkers, with AUCs of 0.776 for FIB, 0.877 for Hcy, and 0.810 for P-SOD. Notably, the combined model achieved superior diagnostic accuracy (AUC = 0.925, 95% CI: 0.88–0.97). These findings indicate that combined assessment of coagulation, metabolic, and oxidative stress markers may improve early diagnosis and risk stratification of SSHL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.